{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:07:48Z","timestamp":1792724868507,"version":"4.5.0"},"reference-count":110,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Chronic kidney disease (CKD) is characterized by manifestations and symptoms involving systemic organs and apparatus, associated with elevated cardiovascular morbidity and mortality, bone disease, and other tissue involvement. Arterial hypertension (AH), diabetes mellitus (DM), and dyslipidemia, with glomerular or congenital diseases, are the traditional risk factors recognized as the main causes of progressive kidney dysfunction evolving into uremia. Acute kidney injury (AKI) has recently been considered an additional risk factor for the worsening of CKD or the development of CKD de novo. Evidence underlies the role of systemic inflammation as a linking factor between AKI and CKD, recognizing the role of inflammation in AKI evolution to CKD. Moreover, abnormal increases in oxidative stress (OS) and inflammatory status in CKD seem to exert an important pathogenetic role, with significant involvement in the clinical management of this condition. With our revision, we want to focus on and update the inflammatory mechanisms responsible for the pathologic conditions associated with CKD, with particular attention on the development of AKI and AKI-CKD de novo, the alteration of calcium-phosphorus metabolism with bone disease and CKD-MBD syndrome, the status of malnutrition and malnutrition\u2013inflammation complex syndrome (MICS) and protein-energy wasting (PEW), uremic sarcopenia, the status of OS, and the different inflammatory pathways, highlighting a new approach to CKD. The depth comprehension of the mechanisms underlying the development of inflammation in CKD may present new possible therapeutic approaches in CKD and hopefully improve the management of correlated morbidities and provide a reduction in associated mortality.<\/jats:p>","DOI":"10.3390\/life11050419","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T22:51:42Z","timestamp":1620255102000},"page":"419","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Chronic Kidney Disease as a Systemic Inflammatory Syndrome: Update on Mechanisms Involved and Potential Treatment"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8867-3979","authenticated-orcid":false,"given":"Francesca","family":"Tinti","sequence":"first","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, Viale dell\u2019Universit\u00e0 37, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7199-2954","authenticated-orcid":false,"given":"Silvia","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, Viale dell\u2019Universit\u00e0 37, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1310-3730","authenticated-orcid":false,"given":"Annalisa","family":"Noce","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, Nephrology and Dialysis Unit, University of Rome Tor Vergata, via Montpellier 1, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silverio","family":"Rotondi","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, Viale dell\u2019Universit\u00e0 37, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5854-2086","authenticated-orcid":false,"given":"Giulia","family":"Marrone","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, Nephrology and Dialysis Unit, University of Rome Tor Vergata, via Montpellier 1, 00133 Rome, Italy"},{"name":"PhD School of Applied Medical, Surgical Sciences, University of Rome Tor Vergata, via Montpellier 1, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3071-1893","authenticated-orcid":false,"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, Viale dell\u2019Universit\u00e0 37, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Di Daniele","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, Nephrology and Dialysis Unit, University of Rome Tor Vergata, via Montpellier 1, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0132-386X","authenticated-orcid":false,"given":"Anna Paola","family":"Mitterhofer","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, Nephrology and Dialysis Unit, University of Rome Tor Vergata, via Montpellier 1, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lopes, J.A., and Raimundo, M. (2011). Metabolic syndrome, chronic kidney disease, and cardiovascular disease: A dynamic and life-threatening triad. Cardiol. Res. Pract., 1.","DOI":"10.4061\/2011\/747861"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: A systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/kisup.2013.79","article-title":"Risk factors for chronic kidney disease: An update","volume":"3","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semnephrol.2016.05.005","article-title":"The Role of Acute Kidney Injury in Chronic Kidney Disease","volume":"36","author":"Hsu","year":"2016","journal-title":"Semin. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Liakopoulos, V., Roumeliotis, S., Gorny, X., Dounousi, E., and Mertens, P.R. (2017). Oxidative Stress in Hemodialysis Patients: A Review of the Literature. Oxid. Med. Cell. Longev., 2017.","DOI":"10.1155\/2017\/3081856"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Podkowi\u0144ska, A., and Formanowicz, D. (2020). Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease. Antioxidants, 9.","DOI":"10.3390\/antiox9080752"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1172\/JCI83470","article-title":"FGF23 signaling impairs neutrophil recruitment and host defense during CKD","volume":"126","author":"Rossaint","year":"2016","journal-title":"J. Clin. Invest."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1152\/ajprenal.00293.2012","article-title":"Isolation of interstitial fluid and demonstration of local proinflammatory cytokine production and increased absorptive gradient in chronic peritoneal dialysis","volume":"304","author":"Rosengren","year":"2013","journal-title":"Am. J. Physiol. - Ren. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Mihai, S., Codrici, E., Popescu, I.D., Enciu, A.M., Albulescu, L., Necula, L.G., Mambet, C., Anton, G., and Tanase, C. (2018). Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J. Immunol. Res., 2018.","DOI":"10.1155\/2018\/2180373"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Noce, A., Albanese, M., Marrone, G., Di Lauro, M., Pietroboni Zaitseva, A., Palazzetti, D., Guerriero, C., Paolino, A., Pizzenti, G., and Di Daniele, F. (2021). Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients. Pharmaceuticals, 14.","DOI":"10.3390\/ph14040336"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.kint.2016.10.021","article-title":"Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease","volume":"91","author":"Isakova","year":"2017","journal-title":"Kidney Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.ajkd.2005.09.014","article-title":"Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD","volume":"47","author":"Honda","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1152\/ajprenal.00421.2009","article-title":"Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure","volume":"298","author":"Kim","year":"2010","journal-title":"Am. J. Physiol. - Ren. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000346689","article-title":"Cytokine secretion and markers of inflammation in relation to acidosis among chronic hemodialysis patients","volume":"35","author":"Ori","year":"2013","journal-title":"Blood Purif."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.molmed.2004.09.003","article-title":"Nrf2-Keap1 defines a physiologically important stress response mechanism","volume":"10","author":"Motohashi","year":"2004","journal-title":"Trends Mol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1101\/gad.225680.113","article-title":"The emerging role of the Nrf2-Keap1 signaling pathway in cancer","volume":"27","author":"Jaramillo","year":"2013","journal-title":"Genes Dev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.numecd.2009.01.009","article-title":"The usefulness of the prognostic inflammatory and nutritional index (PINI) in a haemodialysis population","volume":"19","author":"Noce","year":"2009","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.18632\/aging.100740","article-title":"Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients","volume":"7","author":"Noce","year":"2015","journal-title":"Aging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40620-016-0305-6","article-title":"Vitamin D in patients with chronic kidney disease: A position statement of the Working Group \u201cTrace Elements and Mineral Metabolism\u201d of the Italian Society of Nephrology","volume":"29","author":"Morrone","year":"2016","journal-title":"J. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40620-014-0126-4","article-title":"Homocysteine, cysteine, folate and vitamin B12 status in type 2 diabetic patients with chronic kidney disease","volume":"28","author":"Pastore","year":"2015","journal-title":"J. Nephrol."},{"key":"ref_24","first-page":"370","article-title":"Beneficial effects of physical activity on uremic sarcopenia","volume":"71","author":"Noce","year":"2018","journal-title":"Med. dello Sport"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jtemb.2009.06.005","article-title":"Chronic treatment with statins increases the availability of selenium in the antioxidant defence systems of hemodialysis patients","volume":"24","author":"Noce","year":"2010","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lfs.2018.08.067","article-title":"Oxidative stress \u2013 chronic kidney disease \u2013 cardiovascular disease: A vicious circle","volume":"210","author":"Ravarotto","year":"2018","journal-title":"Life Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/ki.2008.660","article-title":"Periodontal disease adversely affects the survival of patients with end-stage renal disease","volume":"75","author":"Kshirsagar","year":"2009","journal-title":"Kidney Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/ndt\/gft021","article-title":"Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: The potential role of inflammation","volume":"28","author":"Icardi","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S2213-8587(13)70165-7","article-title":"Vitamin D status and ill health: A systematic review","volume":"2","author":"Autier","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_31","first-page":"1","article-title":"Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial","volume":"903","author":"Murai","year":"2021","journal-title":"Jama"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1053\/j.ajkd.2020.08.016","article-title":"Strategies to Treat Obesity in Patients With CKD","volume":"77","author":"Chintam","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/ndt\/gfq246","article-title":"Adipose tissue in renal disease: Clinical significance and prognostic implications","volume":"25","author":"Iglesias","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","article-title":"CKD and nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2014","journal-title":"Am. J. kidney Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Marcuccilli, M., and Chonchol, M. (2016). NAFLD and chronic kidney disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17040562"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1572-0241.2004.40220.x","article-title":"Beneficial effects of tumor necrosis factor-\u03b1 inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis","volume":"99","author":"Satapathy","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1159\/000135692","article-title":"Precision of biomarkers to define chronic inflammation in CKD","volume":"28","author":"Laclair","year":"2008","journal-title":"Am. J. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0272-6386(00)70200-9","article-title":"C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"35","author":"Yeun","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Stenvinkel, P., Barany, P., Heimb\u00fcrger, O., Pecoits-Filho, R., and Lindholm, B. (2002). Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6?. Kidney Int. Suppl., 61.","DOI":"10.1046\/j.1523-1755.61.s80.19.x"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","article-title":"Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study","volume":"361","author":"Ketteler","year":"2003","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.mnh.0000441051.36783.f3","article-title":"The link between acute kidney injury and chronic kidney disease","volume":"23","author":"Belayev","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/jama.2009.1322","article-title":"Chronic dialysis and death among survivors of acute kidney injury requiring dialysis","volume":"302","author":"Wald","year":"2009","journal-title":"JAMA"},{"key":"ref_44","unstructured":"(2012). Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. Suppl., 2, 1\u2013138."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ki.2011.42","article-title":"The severity of acute kidney injury predicts progression to chronic kidney disease","volume":"79","author":"Chawla","year":"2011","journal-title":"Kidney Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.ajkd.2012.12.022","article-title":"Biomarkers in Nephrology","volume":"62","author":"McMahon","year":"2013","journal-title":"Am. J. kidney Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinf.2015.11.008","article-title":"Recent advances in pathophysiology and biomarkers of sepsis-induced acute kidney injury","volume":"72","author":"Umbro","year":"2016","journal-title":"J. Infect."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cyto.2014.10.024","article-title":"TNF-\u03b1 depuration is a predictor of mortality in critically ill patients under continuous veno-venous hemodiafiltration treatment","volume":"71","author":"Quinto","year":"2015","journal-title":"Cytokine"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Malard, B., Lambert, C., and Kellum, J.A. (2019). \u201cIn vitro comparison of the adsorption of inflammatory mediators by blood purification devices\u201d: A misleading article for clinical practice?. Intensive Care Med. Exp., 7.","DOI":"10.1186\/s40635-018-0214-1"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(01)00518-9","article-title":"HIF-1, O2, and the 3 PHDs: How animal cells signal hypoxia to the nucleus","volume":"107","author":"Semenza","year":"2001","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1681\/ASN.2008070804","article-title":"HIF in kidney disease and development","volume":"20","author":"Gunaratnam","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1097\/01.ASN.0000092792.97122.E0","article-title":"HIF-1: An Oxygen Response System with Special Relevance to the Kidney","volume":"14","author":"Maxwell","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.ki.5000221","article-title":"The VHL\/HIF oxygen-sensing pathway and its relevance to kidney disease","volume":"69","author":"Haase","year":"2006","journal-title":"Kidney Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1046\/j.1523-1755.2000.00419.x","article-title":"Hypoxia promotes fibrogenesis in human renal fibroblasts","volume":"58","author":"Norman","year":"2000","journal-title":"Kidney Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semnephrol.2018.10.004","article-title":"Dysregulated Mineral Metabolism in AKI","volume":"39","author":"Leaf","year":"2019","journal-title":"Semin. Nephrol."},{"key":"ref_56","first-page":"1","article-title":"Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression","volume":"5","author":"Gao","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1056\/NEJM199011223232104","article-title":"A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group","volume":"323","author":"Bozzette","year":"1990","journal-title":"New English J. Med."},{"key":"ref_58","first-page":"211","article-title":"Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: Role of TNF-alpha and IL-1-beta","volume":"81","author":"Cunha","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the Eye of the Cytokine Storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_60","first-page":"262","article-title":"Alpha1-microglobulin as an early biomarker of sepsis-associated acute kidney injury: A prospective cohort study","volume":"18","author":"Terzi","year":"2014","journal-title":"Hippokratia"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3947\/ic.2014.46.1.1","article-title":"Biomarkers of Sepsis","volume":"46","author":"Cho","year":"2014","journal-title":"Infect. Chemother."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2009.07.020","article-title":"Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysis","volume":"54","author":"Haase","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Xu, J., Zhao, S., Teng, T., Abdalla, A.E., Zhu, W., Xie, L., Wang, Y., and Guo, X. (2020). Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses, 12.","DOI":"10.3390\/v12020244"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., and Xu, G. (2020). Kidney impairment is associated with in-hospital death of COVID-19 patients. medRxiv.","DOI":"10.1101\/2020.02.18.20023242"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa030685","article-title":"A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong","volume":"348","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Hua","year":"2020","journal-title":"Kidney Int."},{"key":"ref_68","first-page":"1","article-title":"Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19","volume":"38","author":"Yan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMc2011117","article-title":"Covid-19 and Kidney Transplantation","volume":"328","author":"Akalin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.kint.2020.03.001","article-title":"The Novel Coronavirus 2019 epidemic and kidneys","volume":"97","author":"Naicker","year":"2020","journal-title":"Kidney Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/ndt\/gft514","article-title":"Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?","volume":"29","author":"Cozzolino","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00223-020-00794-0","article-title":"Inflammation, Oxidative Stress, and Bone in Chronic Kidney Disease in the Osteoimmunology Era","volume":"108","author":"Mazzaferro","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/157016110791112313","article-title":"The fibroblast growth factor 23: A new player in the field of cardiovascular, bone and renal disease","volume":"8","author":"Cozzolino","year":"2010","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000468952","article-title":"Fibroblast Growth Factor 23: Mineral Metabolism and beyond","volume":"190","author":"Grabner","year":"2017","journal-title":"Contrib. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD","volume":"25","author":"Scialla","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.semnephrol.2014.09.006","article-title":"News on Biomarkers in CKD-MBD","volume":"34","author":"Mazzaferro","year":"2014","journal-title":"Semin. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1053\/ajkd.2001.29250","article-title":"Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients","volume":"38","author":"Kopple","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"ref_82","first-page":"1094","article-title":"Subjective global assessment of nutrition in dialysis patients","volume":"8","author":"Enia","year":"1993","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nut.2018.12.005","article-title":"Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy","volume":"62","author":"Lai","year":"2019","journal-title":"Nutrition"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/MNH.0000000000000318","article-title":"Clinical relevance of sarcopenia in chronic kidney disease","volume":"26","author":"Moorthi","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases","volume":"65","author":"Bauersachs","year":"2015","journal-title":"Hypertension"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: A mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.105.539122","article-title":"Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria","volume":"112","author":"Quinkler","year":"2005","journal-title":"Circulation"},{"key":"ref_88","unstructured":"Patel, V., Joharapurkar, A., and Jain, M. (2020). Role of mineralocorticoid receptor antagonists in kidney diseases. Drug Dev. Res., 1\u201323."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2013.00115","article-title":"PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy","volume":"4","author":"Orena","year":"2013","journal-title":"Front. Pharmacol."},{"key":"ref_90","first-page":"606","article-title":"The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomerulonephritis","volume":"4","author":"Zitt","year":"2011","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-8587(18)30141-4","article-title":"Canagliflozin and renal outcomes in type 2 diabetes: Results from the CANVAS Program randomised clinical trials","volume":"6","author":"Perkovic","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.metabol.2018.02.002","article-title":"Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes","volume":"85","author":"Garvey","year":"2018","journal-title":"Metabolism."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"A1830","DOI":"10.1016\/S0735-1097(18)32371-4","article-title":"Empagliflozin and Canagliflozin Attenuate Inflammatory Cytokines Interferon-\u039b, Tumor Necrosis Factor-\u0391, Interleukin-6: Possible Mechanism of Decreasing Cardiovascular Risk in Diabetes Mellitus","volume":"71","author":"Tan","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Kawanami, D., Matoba, K., Takeda, Y., Nagai, Y., Akamine, T., Yokota, T., Sango, K., and Utsunomiya, K. (2017). SGLT2 inhibitors as a therapeutic option for diabetic nephropathy. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18051083"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0100777","article-title":"Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db\/db mice","volume":"9","author":"Terami","year":"2014","journal-title":"PLoS One"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/dom.13301","article-title":"Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers","volume":"20","author":"Dekkers","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Noce, A., Marrone, G., Di Lauro, M., Urciuoli, S., Pietroboni Zaitseva, A., Wilson Jones, G., Di Daniele, N., and Romani, A. (2020). Cardiovascular Protection of Nephropathic Male Patients by Oral Food Supplements. Cardiovasc. Ther., 2020.","DOI":"10.1155\/2020\/1807941"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/sdi.12030","article-title":"Is Vitamin C Intake too Low in Dialysis Patients?","volume":"26","author":"Raimann","year":"2013","journal-title":"Semin. Dial."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/ckj\/sfx158","article-title":"Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease","volume":"11","author":"Gillis","year":"2018","journal-title":"Clin. Kidney J."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Noce, A., Bocedi, A., Campo, M., Marrone, G., Di Lauro, M., Cattani, G., Di Daniele, N., and Romani, A. (2020). A pilot study of a natural food supplement as new possible therapeutic approach in chronic kidney disease patients. Pharmaceuticals, 13.","DOI":"10.3390\/ph13070148"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Lai, S., Petramala, L., Muscaritoli, M., Cianci, R., Mazzaferro, S., Mitterhofer, A.P., Pasquali, M., D\u2019Ambrosio, V., Carta, M., and Ansuini, M. (2020). \u0391-Lipoic Acid in Patients With Autosomal Dominant Polycystic Kidney Disease. Nutrition, 71.","DOI":"10.1016\/j.nut.2019.110594"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1681\/ASN.2006060639","article-title":"Protective role of hypoxia-inducible factor-2\u03b1 against ischemic damage and oxidative stress in the kidney","volume":"18","author":"Kojima","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/TP.0000000000002085","article-title":"The Impact of Combined Warm Ischemia Time on Development of Acute Kidney Injury in Donation after Circulatory Death Liver Transplantation: Stay Within the Golden Hour","volume":"102","author":"Kalisvaart","year":"2018","journal-title":"Transplantation"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"9314","DOI":"10.3748\/wjg.v22.i42.9314","article-title":"Acute kidney injury and post-reperfusion syndrome in liver transplantation","volume":"22","author":"Umbro","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-019-02139-4","article-title":"Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis","volume":"17","author":"Lai","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Romani, A., Bernini, R., Noce, A., Urciuoli, S., Lauro, M.D., Zaitseva, A.P., Marrone, G., and Daniele, N. (2020). Di Potential beneficial effects of extra virgin olive oils characterized by high content in minor polar compounds in nephropathic patients: A pilot study. Molecules, 25.","DOI":"10.3390\/molecules25204757"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Noce, A., Marrone, G., Urciuoli, S., Di Daniele, F., Di Lauro, M., Zaitseva, A.P., Di Daniele, N., and Romani, A. (2021). Usefulness of extra virgin olive oil minor polar compounds in the management of chronic kidney disease patients. Nutrients, 13.","DOI":"10.3390\/nu13020581"},{"key":"ref_110","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int., 3, 1\u2013150."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/11\/5\/419\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:57:18Z","timestamp":1760162238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/11\/5\/419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":110,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["life11050419"],"URL":"https:\/\/doi.org\/10.3390\/life11050419","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]}}}